The Bile Acid Signaling Axis: Deciphering the Roles of FXR and TGR5 in Hepatic Steatosis, Fibrosis, and Cancer
Pharmacology Research & Perspectives · 2026
DOI: 10.1002/prp2.70318 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacology Research & Perspectives, 2026. Verfasst von Jie Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Bile Acids and Salts, Receptors, Cytoplasmic and Nuclear, Liver Neoplasms. Die Arbeit nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U24A20793, 82260843, QZYY-2025-073, ZSKH HZ (2025) 131.
Abstract (Originalsprache)
Bile acids (BAs) serve not only as emulsifiers for lipid digestion but also as essential signaling molecules, governing various physiological and pathological processes through their interaction with the farnesoid X receptor (FXR) and the takeda G protein‐coupled receptor 5 (TGR5). In recent years, the critical roles of FXR and TGR5 in ameliorating hepatic steatosis, modulating inflammatory responses, and regulating glucose and lipid metabolism, as well as in cholestasis, have gained significant recognition, positioning them as pivotal targets in liver disease research. This article offers a comprehensive review of the structural characteristics and physiological functions of both FXR and TGR5, highlighting their integral contributions to the pathogenesis and progression of various liver diseases, including metabolic dysfunction‐associated steatotic liver disease (MASLD), cholestatic liver disease (CLD), liver fibrosis, and liver cancer. Additionally, it examines the latest advancements in the research and development of pharmacological agents targeting FXR and TGR5, encompassing both agonists and antagonists, and explores their potential clinical applications. A thorough understanding of the FXR and TGR5 signaling pathways will provide a critical theoretical foundation for the development of treatment strategies for liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Guizhou Engineering Research Center of Industrial Key-technology for Dendrobium Nobile, Guizhou Engineering Research Center for Orchid Medicinal Plant Breeding and Efficient Application, Zunyi Medical University, Zunyi,…
Förderung
- U24A20793, 82260843
- QZYY-2025-073
- ZSKH HZ (2025) 131
- QKHPTRC-CXTD
Zitieren
APA
Liu, J., Sun, K., Liu, H., Zhu, M., Li, C., He, Y., & Qin, L. (2026). The Bile Acid Signaling Axis: Deciphering the Roles of FXR and TGR5 in Hepatic Steatosis, Fibrosis, and Cancer. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70318
Vancouver
Liu J, Sun K, Liu H, Zhu M, Li C, He Y, et al. The Bile Acid Signaling Axis: Deciphering the Roles of FXR and TGR5 in Hepatic Steatosis, Fibrosis, and Cancer. Pharmacology Research & Perspectives. 2026. doi:10.1002/prp2.70318
BibTeX
@article{Liu2026,
author = {Liu, Jie and Sun, Kui and Liu, Hongmei and Zhu, Meiyang and Li, Chunmeng and He, Yuqi and Qin, Lin},
title = {The Bile Acid Signaling Axis: Deciphering the Roles of FXR and TGR5 in Hepatic Steatosis, Fibrosis, and Cancer},
journal = {Pharmacology Research & Perspectives},
year = {2026},
doi = {10.1002/prp2.70318}
}
EUVIMED